Showing 6451-6460 of 18631 results for "".
Debunking gMG Myths: Counseling Strategies That Change the Conversation
https://reachmd.com/programs/neurofrontiers/debunking-gmg-myths-counseling-strategies-that-change-the-conversation/35494/Misconceptions about disease progression and exercise are common among patients with generalized myasthenia gravis (gMG), especially early in their diagnosis. This underscores the importance of using relatable analogies and simplified explanations to help patients better understand their disease soPediatric Responses to SARS-CoV-2: What We’ve Learned So Far
https://reachmd.com/programs/clinicians-roundtable/pediatric-responses-to-sars-cov-2-what-weve-learned-so-far/35464/Since the start of the COVID-19 pandemic, our understanding of how children respond to the virus has grown significantly. Join Dr. Diego Hijano as he breaks down these advancements, including how pediatric immune responses and conditions like multisystemic inflammatory syndrome can inform the way weMapping Brain Atrophy in Schizophrenia
https://reachmd.com/programs/frontlines-schizophrenia/mapping-brain-atrophy-in-schizophrenia/30033/A recent study using coordinate network mapping found that a common brain network links the heterogeneous locations of atrophy in schizophrenia. Join Dr. Ahmed Makhlouf as he explains the potential clinical implications of these findings and areas for future research. Dr. Makhlouf is the Medical DirSunscreen as Self-Care
https://practicaldermatology.com/series/c-suite-chats/sunscreen-as-self-care/33249/Arielle Moody, product developer at Mama Sol, talks about the importance of sunscreen in beauty routines and how her company is attempting to make it more appealing.DermWire TV Extra: Spironolactone on TikTok
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-extra-spironolactone-on-tiktok/33016/George Washington University clinical instructor of Dermatology Emily Murphy, MD, and medical student Savanna Vidal discuss their research regarding the quality and reliability of information on TikTok about spironolactone for acne treatment.Novel PsO Drug Could Be 'Closest Perception of a Cure,' Dr. Strober Says at Maui Derm
https://reachmd.com/programs/practical-dermatology/novel-pso-drug-could-be-closest-perception-of-a-cure-dr-strober-says-at-maui-derm/32922/A novel monoclonal antibody targeting IL-23 for the treatment of psoriasis offers an extended half-life that will be a key differentiator for patients, according to Bruce Strober, MD, PhD.Dr. Anderson on New Tech That ‘Could be Revolutionary’ at Maui Derm
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/dr-anderson-on-new-tech-that-could-be-revolutionary-at-maui-derm/32921/In-vivo microscopy that will change how dermatologists practice and potentially revolutionary drug delivery systems were among the technologies highlighted by R. Rox Anderson, MD, PhD, during “Innovation in Dermatology 2025: A Look Into the Future of Dermatology” at the Maui Derm Hawaii 2025 meetingJournal Club: Biologics for Young Children
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-biologics-for-young-children/32400/Practical Dermatology Editorial Board member Lawrence Eichenfield, MD, FAAD, Dawn Eichenfield, MD, PhD, discuss the article "Biologic therapies in infants and children younger than 6 years of age with atopic dermatitis: suitability and practical considerations," from Expert Opinion on Drug Safety. RJournal Club: Pediatric Treatment Adherence
https://reachmd.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-pediatric-treatment-adherence/32401/Practical Dermatology Editorial Board members Lawrence Eichenfield, MD, FAAD, Jason Hawkes, MD, MS FAAD, discuss the article "Treatment Adherence in Pediatric Atopic Dermatitis: A Systemic Review," from Pediatric Dermatology as well as their favorite strategies for treatment adherence and the impactJournal Club: Dupilumab and Risk of Malignancy
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-dupilumab-and-risk-of-malignancy/32398/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, speaks with Matthew Zirwas, MD, about the Journal of Allergy and Clinical Immunology: In Practice article "Risk of malignancy associated with use of dupilumab versus other treatments in atopic dermatitis patients: A national database